| Members |
targetComponentId |
| Closed fracture of other parts of bony thorax |
Closed fracture of bones of trunk |
| Closed fracture of other parts of bony thorax |
Closed fracture of bones of trunk |
| Closed fracture of sacrum and coccyx with other cauda equina injury |
Closed fracture of sacrum AND/OR coccyx with cauda equina injury |
| Closed fracture of sacrum and coccyx with other spinal cord injury |
Closed fracture of coccyx |
| Closed fracture of sacrum with spinal cord lesion |
Closed fracture sacrum (disorder) |
| Closed fracture of sacrum without spinal cord injury |
Closed fracture sacrum (disorder) |
| Closed fracture of tibia and fibula, unspecified part |
Closed fracture of lower leg (disorder) |
| Closed fracture of tibia and fibula, unspecified part, NOS |
Closed fracture of lower leg (disorder) |
| Closed fracture of tibia and fibula, unspecified part, NOS |
Closed fracture of lower leg (disorder) |
| Closed fracture of unspecified bone of lower limb |
Fracture of lower limb |
| Closed fracture of vault of skull with intracranial injury of other and unspecified nature |
Closed fracture vault of skull with intracranial injury |
| Closed fracture of vault of skull with other and unspecified intracranial hemorrhage |
Closed fracture of vault of skull with intracranial hemorrhage |
| Closed fracture pelvis, single pubic ramus |
Closed fracture of pubic ramus |
| Closed hindbrain contusion |
Contusion of hindbrain |
| Closed ill-defined fractures of upper limb |
Closed fracture of multiple bones of upper limb |
| Closed inferior dislocation of humerus |
Closed inferior dislocation of glenohumeral joint (disorder) |
| Closed posterior dislocation of humerus |
Closed posterior dislocation of glenohumeral joint (disorder) |
| Closed reduction and application of cast or splint |
Closed reduction of fracture AND application of cast |
| Closed reduction of fracture of zygoma AND/OR zygomatic arch |
Closed reduction of fracture of zygomatic bone (procedure) |
| Closed reduction of vertebral process fracture |
Closed reduction of fracture of vertebra |
| Closed skull fracture with intracranial injury of other and unspecified nature |
Closed skull fracture with intracranial injury |
| Closed skull fracture with other and unspecified intracranial hemorrhage |
Closed skull fracture with intracranial hemorrhage |
| Closed spinal dislocation with anterior thoracic cord lesion |
Anterior lesion of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |
| Closed spinal dislocation with central cervical cord lesion |
Central cord syndrome of cervical spinal cord due to closed dislocation of cervical spine (disorder) |
| Closed spinal dislocation with central lumbar cord lesion |
Central cord syndrome of lumbar spinal cord due to closed spinal dislocation (disorder) |
| Closed spinal dislocation with central thoracic cord lesion |
Central cord syndrome of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |
| Closed spinal dislocation with posterior thoracic cord lesion |
Posterior lesion of thoracic spinal cord due to closed dislocation of joint of thoracic spine |
| Closed spinal dislocation with thoracic cord lesion, unspecified |
Lesion of thoracic spinal cord due to closed dislocation of joint of thoracic spine |
| Closed spinal fracture with central cervical cord lesion, C1-4 |
Central cord syndrome of cervical spinal cord due to closed fracture at C1-C4 level (disorder) |
| Closed spinal fracture with central cervical cord lesion, C5-7 |
Central cord syndrome of cervical spinal cord due to closed fracture at C5-C7 level (disorder) |
| Closed spinal fracture with central lumbar cord lesion |
Central cord syndrome of lumbar spinal cord due to closed spinal fracture (disorder) |
| Closed spinal fracture with central thoracic cord lesion, T1-6 |
Central cord syndrome of thoracic spinal cord due to closed fracture at T1-T6 level (disorder) |
| Closed spinal fracture with central thoracic cord lesion, T7-12 |
Central cord syndrome of thoracic spinal cord due to closed fracture at T7-T12 level (disorder) |
| Closed spinal subluxation with anterior thoracic cord lesion |
Anterior lesion of thoracic spinal cord due to closed subluxation of joint of thoracic spine (disorder) |
| Closed spinal subluxation with central cervical cord lesion |
Central cord syndrome of cervical spinal cord due to closed subluxation of cervical spine (disorder) |
| Closed spinal subluxation with central lumbar cord lesion |
Central cord syndrome of lumbar spinal cord due to closed spinal subluxation (disorder) |
| Closed spinal subluxation with central thoracic cord lesion |
Central cord syndrome of thoracic spinal cord due to closed subluxation of joint of thoracic spine |
| Closed spinal subluxation with complete thoracic cord lesion |
Complete lesion of thoracic spinal cord due to closed subluxation of joint of thoracic spine (disorder) |
| Closed spinal subluxation with posterior thoracic cord lesion |
Posterior lesion of thoracic spine due to closed subluxation of joint of thoracic spine (disorder) |
| Closed spinal subluxation with thoracic cord lesion, unspecified |
Lesion of thoracic spinal cord due to subluxation of joint of thoracic spine (disorder) |
| Closet gay |
Homosexual (finding) |
| Clostridium absonum |
Clostridium sardiniense |
| Clostridium barkeri |
Eubacterium barkeri |
| Clostridium botulinum B toxin 5000u/mL injection solution 2mL ampule |
RimabotulinumtoxinB 5000 unit/mL solution for injection |
| Clostridium botulinum, type G |
Clostridium argentiense |
| Clostridium bryantii |
Syntrophospora bryantii |
| Clostridium durum |
Paenibacillus azotofixans |
| Clostridium fervidus |
Caloramator fervidus |
| Clostridium hydroxybenzoicum |
Sedimentibacter hydroxybenzoicus (organism) |
| Clostridium laramiense |
Clostridium estertheticum subspecies laramiense (organism) |
| Clostridium orbiscindens |
Flavonifractor plautii (organism) |
| Clostridium pfennigii |
Oxobacter pfennigii (organism) |
| Clostridium quercicolum |
Dendrosporobacter quercicolus (organism) |
| Clostridium sartagoformum |
Clostridium sartagoforme (organism) |
| Clostridium thermoaceticum |
Moorella thermoacetica |
| Clostridium thermoautotrophicum |
Moorella thermoautotrophica |
| Clostridium thermocopriae |
Thermoanaerobacter thermocopriae (organism) |
| Clostridium thermolacticum |
Thermoclostridium stercorarium subspecies thermolacticum (organism) |
| Clostridium thermosaccarolyticum |
Thermoanaerobacterium thermosaccharolyticum |
| Clostridium thermosaccharolyticum |
Thermoanaerobacterium thermosaccharolyticum |
| Clostridium thermosulfurigenes |
Thermoanaerobacterium thermosulfurigenes |
| Clostridium villosum |
Filifactor villosus |
| Closure by clamp |
Application of clamp (procedure) |
| Closure of artificial opening of small intestine |
Closure of stoma of small intestine |
| Closure of enterovesical fistula |
Repair of fistula involving urinary bladder and intestine (procedure) |
| Closure of fistula |
Closure - action |
| Closure of ileorectal fistula |
Repair of ileorectal fistula |
| Clotrimazole 1% conventional release eye drops |
Clotrimazole only product in ocular dose form |
| Clotrimazole 1% preservative-free eye drops |
Clotrimazole only product in ocular dose form |
| Clotrimazole 100mg suppository |
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) |
| Clotrimazole 10mg tablet |
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
| Clotrimazole 2%+10% cream+applicator |
Product containing only clotrimazole (medicinal product) |
| Clotrimazole 2%+10% cream+applicator |
Product containing only clotrimazole (medicinal product) |
| Clotrimazole 200mg suppository |
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
| Clotrimazole 200mg/1% suppository+cream |
Product containing only clotrimazole (medicinal product) |
| Clotrimazole 500mg suppository |
Clotrimazole 500 mg vaginal tablet |
| Clotrimazole 500mg/2% pessary+cream |
Product containing only clotrimazole (medicinal product) |
| Cloxacillin sodium 125mg/5mL oral solution |
Product containing precisely cloxacillin (as cloxacillin sodium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Clozapine monitoring |
Monitoring of clozapine therapy |
| Co - Cobalt- dietary |
Cobalt |
| Co-beneldopa 12.5mg/50mg dispersible tablet |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
| Co-beneldopa 25mg/100mg dispersible tablet |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-beneldopa 25mg/100mg m/r capsule |
Product containing only benserazide and levodopa (medicinal product) |
| Co-beneldopa 25mg/100mg prolonged-release oral capsule |
Product containing only benserazide and levodopa (medicinal product) |
| Co-careldopa 10mg/100mg tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 25mg/100mg m/r tablet |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
| Co-careldopa 25mg/100mg tablet |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet |
| Co-careldopa 25mg/250mg tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 50mg/200mg m/r tablet |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Co-codamol 8mg/500mg dispersible tablet |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| Co-codaprin 8mg/500mg dispersible tablet |
Aspirin and codeine only product in oral dose form |
| Co-trimoxazole 160mg/800mg dispersible tablet |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
| Co-trimoxazole 16mg/80mg/mL infusion solution 10mL ampule |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| Co-trimoxazole 80mg/400mg dispersible tablet |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-trimoxazole 960mg/10mL intravenous infusion |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| Coagulation Factor VIIa (cattle) |
Coagulation factor VIIa |
| Coagulation Factor XIIa |
Coagulation factor XIIa |
| Coagulation Factor XIa |
Coagulation factor XIa |
| Coagulation Factor Xa |
Coagulation factor Xa |
| Coagulation factor IV |
Calcium |
| Coagulation factor IXa |
Coagulation factor IXa |
FHIR